Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Clinical Study to Evaluate the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Gel Form Applied to Women with Sexual Arousal Disorder

NCT06116045 is registered in ClinicalTrials.gov with Biozeus Biopharmaceutical S.A. as lead sponsor.

NCT NCT06116045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06116045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Clinical Study to Evaluate the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Gel Form Applied to Women with Sexual Arousal Disorder
Lead sponsor
Biozeus Biopharmaceutical S.A.
Phase
Phase 2
Overall status
Recruiting
Start date
October 1, 2024
Completion date
March 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

female sexual arousal disorder, female sexual dysfunction